siRNA
-
53.6亿美元！舶望制药siRNA疗法再出海
融资的机会来了！~ 多家知名VC公司寻找优质投资标的， 感兴趣的管线包括： （1）针对实体瘤的创新性TCE、（2）新靶点/新核素的创新性核药、（3）Abeta双靶点等CNS创新…
-
下一代靶向TMPRSS6的siRNA疗法寻找合作伙伴 | 药时代BD项目
靶向TMPRSS6药物研发领域近期呈现加速发展趋势。作为铁调素的关键负调控因子，TMPRSS6通过调节铁代谢核心激素铁调素的表达，已成为治疗真性红细胞增多症（PV）及铁代谢紊乱等疾…
-
【IND-enabling】siRNA Therapeutics Targeting AGT for Hypertension 【Product for Licensing】
If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~
-
siRNA Therapeutics Targeting PD-L1 for HBV 【Product for Licensing】
If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~
-
siRNA Therapeutics Targeting APP for Alzheimer’s Disease (AD) 【Product for Licensing】
If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~
-
siRNA Therapeutics Targeting Nav1.7 for Chronic Pain 【Product for Licensing】
If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap
-
siRNA Therapeutics Targeting INHBE and another target 【Product for Licensing】
If you are interested in this asset or need more information, please contact DrugTimes BD Team at BD@drugtimes.cn or visit our website at https://www.drugtimes.cn
-
ALK7-targeting siRNA Therapeutics for fat reduction without muscle loss 【Product for Licensing】
If you are interested in this asset or need more information, please contact DrugTimes BD Team at BD@drugtimes.cn or visit our website at https://www.drugtimes.cn
-
A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure 【Product for Licensing】
If you are interested in this product, please contact us at BD@drugtimes.cn. Many thanks!
